190 related articles for article (PubMed ID: 16925460)
1. Periprosthetic osteolysis and its association with RANKL expression.
Veigl D; Niederlová J; Kryštůfková O
Physiol Res; 2007; 56(4):455-462. PubMed ID: 16925460
[TBL] [Abstract][Full Text] [Related]
2. Receptor activator of nuclear factor kappaB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening.
Gehrke T; Sers C; Morawietz L; Fernahl G; Neidel J; Frommelt L; Krenn V
Scand J Rheumatol; 2003; 32(5):287-94. PubMed ID: 14690142
[TBL] [Abstract][Full Text] [Related]
3. Blockade of XCL1/Lymphotactin Ameliorates Severity of Periprosthetic Osteolysis Triggered by Polyethylene-Particles.
Tian Y; Terkawi MA; Onodera T; Alhasan H; Matsumae G; Takahashi D; Hamasaki M; Ebata T; Aly MK; Kida H; Shimizu T; Uetsuki K; Kadoya K; Iwasaki N
Front Immunol; 2020; 11():1720. PubMed ID: 32849609
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand as markers of periprosthetic osteolysis.
Granchi D; Pellacani A; Spina M; Cenni E; Savarino LM; Baldini N; Giunti A
J Bone Joint Surg Am; 2006 Jul; 88(7):1501-9. PubMed ID: 16818976
[TBL] [Abstract][Full Text] [Related]
5. Elevation of serum tumor necrosis factor α in patients with periprosthetic osteolysis: a case-control study.
Chaganti RK; Purdue E; Sculco TP; Mandl LA
Clin Orthop Relat Res; 2014 Feb; 472(2):584-9. PubMed ID: 24307062
[TBL] [Abstract][Full Text] [Related]
6. The role of RANKL/RANK/OPG system in the canine model of hip periprosthetic infection osteolysis.
Zhang HW; Peng L; Li WB; Song KG
Int J Artif Organs; 2017 Feb; 39(12):619-624. PubMed ID: 28127738
[TBL] [Abstract][Full Text] [Related]
7. [VASCULARITY STUDY ON PERIPROSTHETIC TISSUES AROUND ASEPTIC LOOSENING AFTER TOTAL HIP ARTHROPLASTY].
Wu W; Yan M; Zhu Z; Dai K
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Jan; 30(1):39-43. PubMed ID: 27062844
[TBL] [Abstract][Full Text] [Related]
8. Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin.
Crotti TN; Smith MD; Findlay DM; Zreiqat H; Ahern MJ; Weedon H; Hatzinikolous G; Capone M; Holding C; Haynes DR
Biomaterials; 2004 Feb; 25(4):565-73. PubMed ID: 14607494
[TBL] [Abstract][Full Text] [Related]
9. Ceramic-on-ceramic THA associated with fewer dislocations and less muscle degeneration by preserving muscle progenitors.
Hernigou P; Roussignol X; Delambre J; Poignard A; Flouzat-Lachaniette CH
Clin Orthop Relat Res; 2015 Dec; 473(12):3762-9. PubMed ID: 26054482
[TBL] [Abstract][Full Text] [Related]
10. Alteration of the RANKL/RANK/OPG System in Periprosthetic Osteolysis with Septic Loosening.
Wang L; Dai Z; Xie J; Liao H; Lv C; Hu Y
Inflammation; 2016 Feb; 39(1):218-227. PubMed ID: 26294373
[TBL] [Abstract][Full Text] [Related]
11. Expression of RANKL in osteolytic membranes: association with fibroblastic cell markers.
Ramage SC; Urban NH; Jiranek WA; Maiti A; Beckman MJ
J Bone Joint Surg Am; 2007 Apr; 89(4):841-8. PubMed ID: 17403809
[TBL] [Abstract][Full Text] [Related]
12. Wear particles and ions from cemented and uncemented titanium-based hip prostheses-a histological and chemical analysis of retrieval material.
Grosse S; Haugland HK; Lilleng P; Ellison P; Hallan G; Høl PJ
J Biomed Mater Res B Appl Biomater; 2015 Apr; 103(3):709-17. PubMed ID: 25051953
[TBL] [Abstract][Full Text] [Related]
13. The correlation of RANK, RANKL and TNFalpha expression with bone loss volume and polyethylene wear debris around hip implants.
Holding CA; Findlay DM; Stamenkov R; Neale SD; Lucas H; Dharmapatni AS; Callary SA; Shrestha KR; Atkins GJ; Howie DW; Haynes DR
Biomaterials; 2006 Oct; 27(30):5212-9. PubMed ID: 16806459
[TBL] [Abstract][Full Text] [Related]
14. Alendronate stimulates osteoprotegerin expression in fibroblasts from periprosthetic membrane.
Qian Y; Zhang XL; Jiang Y; Zeng BF; Wang Q; Chen Y; Shen H; Wang Q
Hip Int; 2015; 25(6):581-4. PubMed ID: 26351115
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical Detection of Mast and Dendritic Cells in Periprosthetic Tissues of Aseptically Loosened Total Prostheses].
Vaculová J; Hurník P; Gallo J; Žiak D; Motyka O
Acta Chir Orthop Traumatol Cech; 2018; 85(5):351-358. PubMed ID: 30383532
[TBL] [Abstract][Full Text] [Related]
16. [EXPRESSION OF RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-κB LIGAND IN PERIPHERAL BLOOD OF PATIENTS WITH ASEPTIC LOOSENING OF THE IMPLANT AFTER TOTAL HIP APTHROPLASTY].
Hou K; Wang Y; Lu X; Yang K; Kong W; Li Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Jul; 28(7):853-6. PubMed ID: 26462349
[TBL] [Abstract][Full Text] [Related]
17. Periprosthetic tissue metal content but not serum metal content predicts the type of tissue response in failed small-diameter metal-on-metal total hip arthroplasties.
Lohmann CH; Meyer H; Nuechtern JV; Singh G; Junk-Jantsch S; Schmotzer H; Morlock MM; Pflüger G
J Bone Joint Surg Am; 2013 Sep; 95(17):1561-8. PubMed ID: 24005196
[TBL] [Abstract][Full Text] [Related]
18. Polyethylene wear particles do not induce inflammation or gelatinase (MMP-2 and MMP-9) activity in fibrous tissue interfaces of loosening total hip arthroplasties.
De Jong PT; Tigchelaar W; Van Noorden CJ; Van der Vis HM
Acta Histochem; 2011 Sep; 113(5):556-63. PubMed ID: 20656340
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Outcomes After Metal-on-Metal Total Hip Arthroplasty With a 28-mm Head: A 17- to 23-Year Follow-Up Study of a Previous Report.
Moon JK; Kim Y; Hwang KT; Yang JH; Oh YH; Kim YH
J Arthroplasty; 2018 Jul; 33(7):2165-2172. PubMed ID: 29656971
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of receptor activator of nuclear factor-kappaB ligand (RANKL), inflammatory cytokines, and chemokines in periprosthetic osteolysis of loosened total hip arthroplasty.
Wang CT; Lin YT; Chiang BL; Lee SS; Hou SM
Biomaterials; 2010 Jan; 31(1):77-82. PubMed ID: 19781765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
